Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume 23, Issue 6, Pages 519-524
Publisher
Informa UK Limited
Online
2015-02-25
DOI
10.3109/1061186x.2015.1015536
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Xuyang Jiao et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Meng-Tao Ma et al. CANCER LETTERS
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
- (2013) Ziyad Binkhathlan et al. CURRENT CANCER DRUG TARGETS
- Hepatobiliary Malignancies: Lessons from Asia
- (2013) Tiffany C.L. Wong et al. DIGESTIVE DISEASES
- MicroRNA-200c Regulates the Sensitivity of Chemotherapy of Gastric Cancer SGC7901/DDP Cells by Directly Targeting RhoE
- (2013) Liang Chang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Nrf2 Pathway Regulates Multidrug-Resistance-Associated Protein 1 in Small Cell Lung Cancer
- (2013) Lili Ji et al. PLoS One
- Carcinoma hepatocelular: epidemiologia, biologia, diagnóstico e terapias
- (2013) Marcos António Gomes et al. Revista da Associacao Medica Brasileira
- Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
- (2011) Jin Hou et al. CANCER CELL
- Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs
- (2011) Florie Borel et al. HEPATOLOGY
- Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
- (2011) Xiaohong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion and side populations
- (2010) F Wang et al. BRITISH JOURNAL OF CANCER
- Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis
- (2010) Linlang Guo et al. EUROPEAN JOURNAL OF CANCER
- Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin
- (2010) Sara Vander Borght et al. LIVER INTERNATIONAL
- Roles of small RNAs in tumor formation
- (2010) Gianpiero Di Leva et al. TRENDS IN MOLECULAR MEDICINE
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR-320 IN INSULIN-RESISTANT 3T3-L1 ADIPOCYTES
- (2009) Hong-Yan Ling et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started